Drug profile · INN
chlordiazepoxide hydrochloride
CHLORDIAZACHEL
chlordiazepoxide hydrochloride (CHLORDIAZACHEL) is a gaba-a receptor; anion channel positive allosteric modulator. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
Drug details — chlordiazepoxide hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 3
- Programs
- 0
- Data quality
- 0.89
Quick answer
chlordiazepoxide hydrochloride (CHLORDIAZACHEL) is a gaba-a receptor; anion channel positive allosteric modulator. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
GABA-A receptor; anion channel positive allosteric modulator
Primary target: GABA-A receptor; anion channel
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Related patents
-
US 11484501
Mechanochemical activated dry amorphisation by milling equilibrium between ap mesoporous silica
granted -
US 11478424
Mechanochemcial activated dry amorphisation by milling equilibrium between AP mesoporous silica
granted -
US 6132724
Allelic polygene diagnosis of reward deficiency syndrome and treatment
expired
Frequently asked questions
What is chlordiazepoxide hydrochloride?
chlordiazepoxide hydrochloride (CHLORDIAZACHEL) is a gaba-a receptor; anion channel positive allosteric modulator. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for chlordiazepoxide hydrochloride?
CHLORDIAZACHEL is a marketed brand name for chlordiazepoxide hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of chlordiazepoxide hydrochloride?
chlordiazepoxide hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.